In 1930, Will Keith Kellogg, the breakfast-cereal magnate, endowed a new philanthropic institution with a simple mission: to promote the health and happiness of children. Like many industrialists of his time, he believed that the wealth created by modern business should serve the public good. The W.K. Kellogg Foundation was born from that ideal, funded by stock in the company that still bears his name.
Nearly a century later, that relationship endures. The Foundation’s trust remains one of the largest shareholders in the Kellogg Company—now split into Kellanova (snacks) and WK Kellogg Co (cereals). The dividends from those shares sustain one of the world’s largest charitable foundations, supporting programs in early childhood, food security, and public health.
But the Foundation’s history reveals a deeper paradox—one that raises uncomfortable questions about how philanthropy, industry, and science can become entangled in shaping public health itself.
Sugar, Tooth Decay, and the Birth of Fluoridation
By the mid-20th century, Americans were consuming record amounts of refined sugar, much of it through breakfast cereals and convenience foods. Dental caries became one of the most common chronic diseases in children.
Rather than confronting the role of sugar, public-health officials and industry leaders rallied around a technological fix: fluoridation. Adding fluoride to drinking water, they claimed, would strengthen enamel and prevent cavities regardless of diet.
The idea was not born in dental science alone—it was also nurtured by industry influence. According to a 2025 analysis by Chris Neurath in Environmental Health, the sugar industry and its allies actively promoted fluoridation to deflect attention from the role of sugar in tooth decay. Among the most prominent actors in this alliance was the W.K. Kellogg Foundation, whose deep financial ties to the sugary cereal business gave it both motive and means to shape dental policy.
The Kellogg Connection
Neurath’s research reveals that in 1942, Emory Morris—a former dentist, Kellogg Company executive, and later president of the W.K. Kellogg Foundation—was appointed chair of the American Dental Association’s Committee on Dental Health Policy. Under his leadership, the ADA began to promote fluoride as a “magic bullet” against tooth decay while de-emphasizing the importance of reducing sugar consumption.
That same year, Morris’s committee even discussed the compulsory addition of fluoride to food.
Soon after, Harold Hillenbrand, editor of the Journal of the American Dental Association (JADA) and a fluoridation advocate, joined the Kellogg Foundation’s dental advisory committee, while Morris simultaneously chaired the ADA’s policy committee—a reciprocal relationship that aligned the Foundation and the ADA in promoting fluoridation.
According to University of Michigan dentist Philip Jay, who led the first human fluoridation trial in Grand Rapids, Michigan, the Kellogg Foundation provided the initial funding for that study in 1945. A decade later, the Foundation gave the ADA a $250,000 grant—worth roughly $2.8 million today—and continued to fund fluoridation programs for decades, including in Latin America as late as 2005. (See link for article)
_______________
**Comment**
The devastating role of sugar and fluoride on human health has been covered up for decades.
“….fluoridation and the proclaimed benefit of fluoride as a way of preventing dental decay is perhaps the greatest “scientific” fraud ever perpetrated upon an unsuspecting public.”
It’s important to note that fluorides are cumulative toxins which means they accumulate in the body.
In 1998 EPA scientists declared a 4ppm safety level; however, this level was set fraudulently by outside forces in a decision that omitted 90% of the data showing the mutagenic properties of fluoride.
Since fluoride is now everywhere, it’s impossible to accurately measure total fluoride intake.
Regarding sugar, “That Sugar Film” documentary follows filmmaker Damon Gameau as went from consuming very little sugar to consuming the average amount of sugar eaten daily by Australians (160gm or 40 teaspoons). He noted:
When many people see a big, beautiful pile of colorful autumn leaves, it feels like an open invitation to dive in. The scene evokes joy, nostalgia, and the simple thrill of childhood.
But for Isabel Rose, it brings up something very different. It reminds her of a moment that marked the beginning of her lifelong struggle with Lyme disease.
What others see as innocent fun, she now views with alarm.
Ticks thrive in damp, shaded environments close to the ground. Leaf piles, tall grass, and wooded edges are prime habitats for them. Children playing in these areas are at increased risk, often unaware that a single tick bite can lead to years of misery.
For Isabel, what began as a carefree childhood leap into a leaf pile became the start of a medical nightmare.
Isabel is now a writer, Lyme disease advocate, and founder of Mothers Against Lyme, a support network for families affected by congenital and pediatric Lyme. She also serves on the board of Project Lyme, a national nonprofit.
In a recent essay published on her Substack, Isabel shares the story of how a tick bite at age 8 led to decades of misdiagnosed symptoms, chronic illness, and eventually, the discovery that both she and her children had Lyme disease and co-infections.
Her experience is a powerful reminder of the importance of tick awareness. Ignoring the risks can be hazardous to yourself–and future generations.
While ticks can’t fly on their own, I’ve seen them be blown in wind. I’ve also heard a story of a person walking through the forest out east where tick populations are high. They heard what sounded like rain drops falling, but it wasn’t rain. It was ticks dropping from trees!
This year marks a major milestone for the MyLymeData patient registry—our 10th anniversary. MyLymeData is a project of LymeDisease.org. Over the past decade, MyLymeData has transformed the landscape of Lyme disease research by putting patients at the center.
Click on image to view larger image
Download Your 32 page full color
2025 MyLymeData Chart Book
Capturing information about patients with chronic Lyme disease that was previously unknown.
To celebrate, we’re publishing the MyLymeData 2025 Research Chartbook—a visual summary of a decade of groundbreaking research, collaboration, and progress. The chartbook transforms the individual experiences of over 19,000 patients into actionable insights. It highlights the extraordinary power of patient-driven research to impact science and promote public policy change.
Since its launch, MyLymeData has:
Enrolled over 19,000 participants
Collected tens of millions of data points on symptoms, treatments, and outcomes
Contributed to multiple National Science Foundation awards, working with artificial intelligence and academic researchers
Published eight peer-reviewed big-data studies that have been cited over 100 times by other scientific publications and in reports to Congress
Recognition and Collaboration
The importance of MyLymeData was recognized by the National Academies of Science, Engineering, and Medicine in its report on the future direction of Lyme disease research. Most recently, we received a Congressionally Directed Medical Research Program grant to use artificial intelligence and data from the registry to better define and understand persistent neurological Lyme disease.
The MyLymeData 2025 Research Chartbook is a celebration of what we’ve accomplished together—and a springboard for what comes next.
Our work is deeply collaborative. We partner with the Lyme Disease Biobank (a Bay Area Lyme Foundation project), academic researchers from institutions including the University of California, Los Angeles, the University of Washington, Johns Hopkins University, the College of New Jersey, and industry scientists. We’ve also served on panels and advisory boards for the National Academies of Sciences, Engineering, and Medicine; the Tick-Borne Disease Working Group; the International Lyme and Associated Diseases Society; and the Columbia Clinical Trials Research Network.
None of this would be possible without the patients who power this registry. Your willingness to share your experiences has fueled a decade of progress and helped shape the future of Lyme disease research. We are deeply grateful for your trust, your data, and your voice.
If you are a patient who is not enrolled in MyLymeData, please enroll today. If you are a researcher who wants to collaborate with us, please contact me directly.
MyLymeData is one of the largest patient-driven registries in the nation, with over 19,000 patients enrolled. It was created by patients, is run by patients and will address the issues that Lyme disease patients care about. MyLymeData Viz provides the community with results from MyLymeData. If you are enrolled in MyLymeData, we thank you for providing the data that will accelerate the pace of research in Lyme disease. If you are not enrolled, please enroll today.
I found the following table most interesting which can be found in top link:
This table shows side effects from the clot shot in both the general population as well as those with Lyme/MSIDS. In short, nearly everyone in both groups had pain at the injection site. Most frightening is that anywhere from 60-70% experienced fatigue, anywhere from 40-63% headache,30-60% muscle pain, and 23-45% joint pain.
The article aptly states:
It is possible that patients reporting Lyme flare-ups misattributed COVID vaccination side effects to Lyme disease since many of the symptoms overlap.
Sadly, the article regurgitates false statistics – namely that 32 million people in the US have been infected with the COVID, and more than 500,000 have died.
The CDC combined test results that diagnose current COVID infections with test results that measure someone has ever had the virus. Those that once had the virus but are well aren’t sick!
Spain’s Constitutional Court has struck down all Covid pandemic-era penalties, ruling that the country’s draconian 2020 restrictions violated citizens’ rights.
The court ruled that lockdowns, “vaccines” mandates, mask policies, and other restrictions illegally suspended basic freedoms.
According to The Objective, more than 92,000 fines have already been annulled as of September 3, 2025.
However, this is just the beginning.
The court’s ruling applies retroactively to all penalties imposed during the first lockdown, when more than 1 million fines were handed out nationwide.
In total, an estimated 1.3 million Spaniards were punished for violating government-imposed restrictions.
The ruling exposes the lockdown for what many critics argued all along: a massive power grab.
The court’s decision confirms that the policies unlawfully trampled fundamental rights.
Court Declares Lockdown Measures Unconstitutional
At the center of the decision is Royal Decree 463/2020.
The pandemic-era emergency order banned citizens from leaving their homes during the so-called “state of alarm.”
Spain’s highest court determined that the sweeping prohibition was not just a limitation on movement but a full suspension of constitutional rights.
That level of restriction, the judges ruled, could only have been imposed under a higher-level “state of emergency.”
However, such an order requires much stricter parliamentary oversight, not by decree.
The decision now retroactively voids every fine issued under the unconstitutional order.
Administrative Chaos and Delayed Refunds
While the ruling is clear, enforcement has been chaotic.
The Objective reports that refunds and annulments are proceeding “slowly and unevenly, depending on each territory.”
As such, many Spaniards could be waiting months or even years before they see justice.
So far, only 92,278 cases have been officially revoked.
However, those revoked so far are “just the tip of the iceberg of a regulatory crisis,” the outlet warned.
With over a million penalties still on the books, the scale of the legal and financial fallout could cripple local administrations.
A Regulatory Crisis Exposed
The court’s ruling underscores how Covid lockdowns and other mandates were used to suspend civil liberties on a massive scale.
These rules were bypassing constitutional safeguards in the name of “public health.”
For years, citizens were fined, harassed, and even criminalized under the system.
Yet, Spain’s top court has now declared this draconian system was built on unconstitutional foundations.
Critics say the judgment proves what medical freedom advocates warned throughout the pandemic: governments weaponized emergency powers to crush individual rights.
Ultimately, it was ordinary people who paid the price.
______________
**Comment**
Considering all the draconian measures were based upon fairy dust, I truly hope people wake up and contact their representatives with data and facts based upon properly done science – instead of the accepted dogma which is all based on sham-wizardry.
“TechImmune, LLC has been awarded a business (SBIR) grant from the U.S. National Institute of Allergy and Infectious Diseases (NIH) to develop a Universal Vaccine Against Multiple Coronavirus Variants of Concern. Additional grants are pending.” Scientific Advisor
Dr. Redfield is the former Director of the Centers for Disease Control and Prevention and a distinguished public health leader with decades of experience in medicine and research. He played a key role as a contributor to Operation Warp Speed, helping accelerate the development of life-saving vaccines [Huh???] during the COVID-19 pandemic. Today, he continues to advance the field through his active involvement in Long COVID clinical research.
Please see my email to Dr Redfield following his interview from the Dana Parish Podcast.
———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: “rrredfieldmd@gmail.com” <rrredfieldmd@gmail.com>
Cc: dana@danaparish.com, sephillips18@gmail.com, skottilil@ihv.umaryland.edu
Date: 11/06/2025 10:39 AM EST
Subject: The Dana Parish Podcast; Dr. Redfield Breaks His Silence — Long COVID, Cancer & Vaccines [And Chronic Lyme]
The Dana Parish Podcast
Dr. Redfield Breaks His Silence — Long COVID, Cancer & Vaccines [And Chronic Lyme] http://
Excerpt:
Dana Parish: “Why are we still suffering like this… it is known at the upper echelons of Public Health that Lyme is chronic.”
Dr. Redfield: “Cause people can’t get a simple diagnostic test to prove it.”
Institute of Human Virology, University of Maryland
725 West Lombard St, Room N560
Baltimore, MD 21201
Dr. Redfield,
You are mistaken. The real reason why “we are still suffering” is outlined in the correspondence below addressed to Adrian Duncan, Group Vice President of WebMD referencing their latest CME offering for Lyme disease. Google’s Gemini AI describes it as: intent to deceive for financial gain.
Carl Tuttle
Independent Researcher
Hudson, NH USA
Cc: Shyamasundaran Kottilil, MBBS, PhD
Institute of Human Virology, Director, Clinical Care & Research; Chief, Infectious Diseases; Professor of Medicine
Email sent to Adrian Duncan, Group Vice President WebMD:
#1 ——— Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: aduncan@webmd.net
Cc: cme@medscape.net, caitlin@medlitera.com, naseem@medlitera.com, michelle@medlitera.com
Date: 10/24/2025 12:42 PM EDT
Subject: Medscape Now! Understanding the Latest Evidence and Best Practices for Interprofessional Care of Post-Treatment Lyme Disease Syndrome
“To date, our understanding of the pathophysiology of Lyme IACI remains limited,[4] with little to no evidence supporting chronic Borrelia infection as the underlying cause.”
Adrian Duncan, Group Vice President
Global Head of Education & Medical Affairs
Dear Mr. Duncan,
In reference to the Medscape article written by Naseem Bazargan, I asked Google’s Gemini AI the following questions:
The latest Medscape CME education claiming to be developed with AI assistance, appears to have omitted the following references:
2018 Middelveen study; “Persistent Borrelia Infection in Patients with Ongoing Symptoms of Lyme Disease” identifying twelve patients who were culture positive after antibiotic treatment. Some of these patients had taken as many as eleven different types of antibiotics. Also missing is the NIH funded Embers studies of persistent Bb infection in monkeys and mice. And the Sapi study: “The Long-Term Persistence of Borrelia burgdorferi Antigens and DNA in the Tissues of a Patient with Lyme Disease” Here is the positive culture report from the CDC at Fort Collins Colorado and the chronic Lyme autopsy results from the patient in the Sapi study: Page 1, 2, 3, 4, 5, 6, 7. The destructive nature of Borrelia is evident in the patient’s liver (nutmeg liver), kidneys, heart, lungs and brain. The patient died after the insurer refused additional IV antibiotic therapy.
In fact, there appears to be 700 references identifying persistent infection. Question: So, is AI participating in the collusion to suppress evidence of antibiotic resistance or chronic Lyme disease? And what about the other 700 references identifying persistent infection?
Mr. Duncan… I will spare you the lengthy discourse and get right to the point.
Questions to AI:
1. Does a chronic relapsing seronegative disease fit the vaccine model?
AI Response:
A chronic, relapsing, seronegative disease does not fit the traditional vaccine model, which is primarily designed to prevent initial infections. The characteristics you describe present significant scientific and commercial challenges for vaccine developers.
2. Since you agreed that a chronic, relapsing, seronegative disease does not fit the traditional vaccine model this in and of itself would be the motivation to conceal any and all evidence of persistent infection wouldn’t you agree? This so-called debate is not a debate at all and deserves a criminal investigation. Who would be a suitable candidate to approach for a legal case?
AI Response: Allegations of medical fraud are typically handled as civil matters, but they can become criminal if there is evidence of gross negligence, recklessness, or intent to deceive, especially for financial gain.
Mr. Duncan,
Thirty-four years agoDr. Allen Steere identified chronic Lyme disease which should have set off a red flag prompting an immediate search for better antimicrobials but then did a 180° as he became principal investigator (PI) of the Phase 3 clinical trial for the first Lyme disease vaccine. So all the eggs were put into the vaccine basket while a campaign was orchestrated to discredit the sick and disabled patient population along with the courageous clinicians attempting to help these patients. Apparently, a chronic relapsing seronegative disease did not fit the business model of patent royalties, vaccine development and pharmaceutical profits. This set the stage for long-term treatment denial and unimaginable pain and suffering around the world. It has been ongoing for over three decades now and the latest CME from Medscape is propagating this travesty.
Lyme disease has been grossly mishandled by our public health officials for the sake of a vaccine. A false public health narrative was enforced and any clinician who did not follow that narrative risked losing their license to practice medicine as seen in the documentary: Under our Skin. (please watch the 5min trailer)
I want to make this crystal clear; suppressing evidence of antibiotic resistance is not collaboration, it is collusion. Will you turn a blind eye to the facts/evidence I have presented?
A response to this inquiry is requested.
Respectfully submitted,
#2 ———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>To: aduncan@webmd.netCc: cme@medscape.net, caitlin@medlitera.com, naseem@medlitera.com, michelle@medlitera.comDate: 10/28/2025 9:28 AM EDT
Subject: Re: Medscape Now! Understanding the Latest Evidence and Best Practices for Interprofessional Care of Post-Treatment Lyme Disease Syndrome
Dear Mr. Duncan,
In 2016 Dr. Paul Auwaerter, past president of the Infectious Diseases Society of America coauthored a study revealing the persister form of Borrelia burgdorferi resistant to antibiotics.
-What has tuberculosis and Borrelia burgdorferi in common? In the late stage of the disease occurs persistent (tolerant) bacteria, which essentially means that the bacteria lasts and lasts and lasts. They protect themselves against antibiotics and are difficult to treat.
– Both Borrelia burgdorferi and tuberculosis is relatively easy to cure in the early stages, even with the use of one antibiotic. In the late stage it is impossible to cure the disease with the same type of treatment in the acute phase, said Dr. Ying Zhang when he visited the year NorVect conference.
-Dr. Ying Zhang is a professor at the Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health
-Two days after NorVect conference, published Dr. Ying Zhang’s latest research Identification of new compounds with high activity against stationary phase Borrelia burgdorferi from the NCI compound collection.
2016
A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug Library Jie Feng 1, Wanliang Shi 1, Shuo Zhang 1, David Sullivan 1, Paul G Auwaerter 2, Ying Zhang 1 https://pubmed.ncbi.nlm.nih.gov/27242757/
Abstract
Under experimental stress conditions such as starvation or antibiotic exposure, Borrelia burgdorferi can develop round body forms, which are a type of persister bacteria that appear resistant in vitro to customary first-line antibiotics for Lyme disease. To identify more effective drugs with activity against the round body form of B. burgdorferi, we established a round body persister model induced by exposure to amoxicillin (50 μg/ml) and then screened the Food and Drug Administration drug library consisting of 1581 drug compounds and also 22 drug combinations using the SYBR Green I/propidium iodide viability assay. We identified 23 drug candidates that have higher activity against the round bodies of B. burgdorferi than either amoxicillin or doxycycline.
Lyme disease (LD), caused by Borrelia burgdorferi, is the most common vector-borne disease in the United States and Europe. Despite the standard 2–4 weeks’ antibiotic treatment, approximately 10%–20% of patients will develop posttreatment LD syndrome, a condition that is poorly understood. One of the probable causes is thought to be the presence of B. burgdorferi persister forms that are not effectively killed by the current LD antibiotics. In this study, we evaluated nitroxoline, an antibiotic used to treat urinary tract infections, for its activity against a stationary-phase culture enriched with persister forms of B. burgdorferi. Nitroxoline was found to be more active than doxycycline and equally active as cefuroxime (standard LD antibiotics) against B. burgdorferi. Importantly, the nitroxoline two-drug combinations nitroxoline + cefuroxime and nitroxoline + clarithromycin, as well as the nitroxoline three-drug combination nitroxoline + cefuroxime + clarithromycin, were as effective as the persister drug daptomycin-based positive control three-drug combination cefuroxime + doxycycline + daptomycin, completely eradicating stationary-phase B. burgdorferi in the drug-exposure experiments and preventing regrowth in the subculture study. Future studies should evaluate these promising drug combinations in a persistent LD mouse model.
Dr. Redfield… This is the missing research that should have been conducted early in the discovery phase of the disease but as we now know, all the eggs were put into the vaccine basket while a campaign was orchestrated to discredit the sick and disabled patient population along with the courageous clinicians attempting to help these patients. What has been deceitfully established here in the US is wreaking havoc globally. Example: Lyme disease: Australians ‘being treated worse than a dog riddled with mange’, Senator John Madigan says https://www.abc.net.au/news/2016-01-11/lyme-disease-treatment-in-australia-criticised-by-john-madigan/7080708
This research is being suppressed as the disabled Lyme patient population around the globe remain sick indefinitely. (Three decades and counting)
Guideline signatory Dr. Raymond Dattwyler owns 24 patents for Lyme disease that include diagnostic testing and vaccines both live bacteria and oral and endorses the categorical assertion that chronic Lyme disease does not exist yet his patent for novel chimeric nucleic acids and protein antigens which could serve as a basis for a vaccine or for improved immunodiagnostic reagents for Lyme disease, issuing almost contemporaneously with the 2006 IDSA Lyme Disease Guidelines seems to say exactly the opposite:
“Currently, Lyme Disease is treated with a range of antibiotics, e.g. tetracycline, penicillin and cephalosporins. However, such treatment is not always successful in clearing the infection. Treatment is often delayed due to improper diagnosis with the deleterious effect that the infection proceeds to a chronic condition, where treatment with antibiotics is often not useful. One of the factors contributing to delayed treatment is the lack of effective diagnostic tools.” (Dattwyler, et.al. United States Patent 7,179,448)
Please take a moment if you will to review the following inquiry addressed to doctor Dattwyler who has set the stage for long-term treatment denial. It should be noted that there was no response.
———- Original Message ———-
From: CARL TUTTLE <runagain@comcast.net>
To: Raymond_Dattwyler@nymc.edu
Cc: npjvaccines@nature.com, abarrett@utmb.edu, R.W.Titball@exeter.ac.uk, mgomesso@uthsc.eduDate: 01/06/2023 2:46 PM EST
Subject: The year that shaped the outcome of the OspA vaccine for human Lyme disease
Department of Microbiology and Immunology
New York Medical College
Valhalla, NY
Raymond J. Dattwyler, Corresponding Author
Dear Dr. Dattwyler,
I read your manuscript with great interest as you call attention to a treatment-resistant Lyme arthritis with “no evidence of DNA” found in the joints of patients after antibiotic treatment.
For some strange reason however, I could not find the following 1995 publication within your paper identifying treatment-resistant neuroborreliosis:
We report an unusual patient with evidence of Borrelia burgdorferi infection who experienced repeated neurologic relapses despite aggressive antibiotic therapy. Each course of therapy was associated with a Jarisch-Herxheimer-like reaction. Although the patient never had detectable free antibodies to B. burgdorferi in serum or spinal fluid, the CSF was positive on multiple occasions for complexed anti-B. burgdorferi antibodies, B. burgdorferi nucleic acids and free antigen.
In fact, Dr. Dattwyler there seems to be a great deal of “treatment-resistant” evidence published in multiple journals over the past three decades:
Does a chronic relapsing seronegative disease fit the vaccine model? If not, would that, in and of itself, be the hidden reason for denying chronic (treatment-resistant) Lyme disease for almost three decades? In other words, patent royalties and pharmaceutical profits over lifesaving care?
A response to this inquiry is requested.
Carl Tuttle
Hudson, NH
Cc: Alan D.T. Barrett, PhD Editor-in-Chief
Rick Titball, PhD, DSc, Deputy Editor
Dr. Redfield… We have been dealing with an antibiotic resistant/tolerant super-bug. Post Treatment Lyme Disease Syndrome (PTLDS) is simply a fabricated medical condition disguising treatment failure. A chronic relapsing seronegative disease DOES NOT fit the vaccine model because you cannot prove vaccine efficacy in a disease where we don’t know who has or does not have the infection! So, deny the chronically infected by suppressing all evidence of antibiotic resistance, claim that the infection is easily treated because newer curative treatment for all stages of disease would give the public an excuse not to take the vaccine, reject all direct-detection methods that prove chronic infection and voila! move forward with patent royalties, vaccine development and pharmaceutical profits. The federal watchdog is no more. People suffering and dying and for what? Lyme for Profit.
The CDC has propagated this false Lyme disease narrative for decades and to this day refuses to recognize the disabling stage of the disease exposed in the documentaries Under our Skin and The Quiet Epidemic.
You may want to read the following Newsweek article published April 2024 by Lindsay Keys Co-Director of The Quiet Epidemic as it describes precisely what affect suppressing/concealing antibiotic resistance has had on the patient population…
Madison Area Lyme Support Group 